Structural Model for the Interaction of a Designed Ankyrin Repeat Protein with the Human Epidermal Growth Factor Receptor 2

DARPins and other repeat protein scaffolds: advances in engineering and applications

(2011) Ykelien L Boersma et al.   CURRENT OPINION IN BIOTECHNOLOGY

Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size

(2010) C. Zahnd et al.   CANCER RESEARCH

Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer

(2010) Jean-Philippe Theurillat et al.   MODERN PATHOLOGY

DrugScorePPI webserver: fast and accurate in silico alanine scanning for scoring protein–protein interactions

(2010) Dennis M. Kr�ger et al.   NUCLEIC ACIDS RESEARCH

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

(2009) Teemu T. Junttila et al.   CANCER CELL

A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activityin vivo

(2009) Timothy E. Adams et al.   GROWTH FACTORS

Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site

(2009) J. Bostrom et al.   SCIENCE

Parallel kinetic analysis and affinity determination of hundreds of monoclonal antibodies using the ProteOn XPR36

(2008) Oded Nahshol et al.   ANALYTICAL BIOCHEMISTRY

Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display

(2008) Daniel Steiner et al.   JOURNAL OF MOLECULAR BIOLOGY

PDBsum new things

(2008) R. A. Laskowski   NUCLEIC ACIDS RESEARCH

Chaperone-Assisted Crystallography with DARPins

(2008) Gaby Sennhauser et al.   STRUCTURE